Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2019 1
2020 2
2021 2
2022 5
2023 3
2024 4
2025 4
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial.
Sands BE, Irving PM, Hoops T, Izanec JL, Gao LL, Gasink C, Greenspan A, Allez M, Danese S, Hanauer SB, Jairath V, Kuehbacher T, Lewis JD, Loftus EV Jr, Mihaly E, Panaccione R, Scherl E, Shchukina OB, Sandborn WJ; SEAVUE Study Group. Sands BE, et al. Lancet. 2022 Jun 11;399(10342):2200-2211. doi: 10.1016/S0140-6736(22)00688-2. Lancet. 2022. PMID: 35691323 Clinical Trial.
Clinical, Endoscopic, and Histological Characteristics of Severe Immune Checkpoint Inhibitor-Induced Colitis.
Casas Deza D, Polo Cuadro C, Gascón Ruiz M, Barreiro-de Acosta M, Mañosa M, Rodríguez-Moranta F, Zabana Y, Céspedes Martínez E, Ordás I, Miranda Bautista J, García MJ, García de la Filia Molina I, Roig Ramos C, Ruiz Cerulla A, Segarra-Ortega JX, Matallana Royo V, Rodríguez González E, Martínez de Juan F, Manceñido Marcos N, Madero Velázquez L, Betoré Glaría E, Álvarez Herrero B, Suris G, Garrido Marín A, Brunet Mas E, Alonso Abreu I, Santos Fernández J, Vaamonde Lorenzo M, Almingol Crespo C, Folguera C, Sanz Segura P, Moralejo Lozano Ó, López Couceiro L, Tejido Sandoval C, Mena Sánchez R, Sainz E, Marquès-Camí M, Ferreiro-Iglesias R, Ortega Moya SP, Wolfe García PM, Borras Garriga P, Herreros Martínez B, Calvo Iñiguez M, Frago Larramona S, Ladrón Abia P, Serra-Ruiz X, Menchén L, Rivas Rivas C, Mesonero Gismero F, Vicente Lidón R, Gutierrez A, García López S; GETECCU. Casas Deza D, et al. Among authors: vicente lidon r. J Clin Med. 2026 Jan 2;15(1):353. doi: 10.3390/jcm15010353. J Clin Med. 2026. PMID: 41517602 Free PMC article.
Patients Included in Clinical Trials of Biological Drugs for Inflammatory Bowel Disease Do Not Represent the Real-World Population.
Casas Deza D, Larrubia Domínguez C, Pascual Oliver A, Polo Cuadro C, Yagüe Caballero C, Almenara Michelena L, Royo Esteban A, Cotaina Gracia A, Vicente Lidón R, Corsino Roche P, Cardona Usán E, Sirbu Sirbu V, Pardillos Ruiz C, García López S. Casas Deza D, et al. Among authors: vicente lidon r. Am J Gastroenterol. 2025 Jul 30. doi: 10.14309/ajg.0000000000003670. Online ahead of print. Am J Gastroenterol. 2025. PMID: 40736698
Real-World Evidence of Tofacinitib in Ulcerative Colitis: Short-Term and Long-Term Effectiveness and Safety.
Chaparro M, Acosta D, Rodríguez C, Mesonero F, Vicuña M, Barreiro-de Acosta M, Fernández-Clotet A, Hernández Martínez Á, Arroyo M, Vera I, Ruiz-Cerulla A, Sicilia B, Cabello Tapia MJ, Muñoz Villafranca C, Castro-Poceiro J, Martínez Cadilla J, Sierra-Ausín M, Vázquez Morón JM, Vicente Lidón R, Bermejo F, Royo V, Calafat M, González-Muñoza C, Leo Carnerero E, Manceñido Marcos N, Torrealba L, Alonso-Galán H, Benítez JM, Ber Nieto Y, Diz-Lois Palomares MT, García MJ, Muñoz JF, Armesto González EM, Calvet X, Hernández-Camba A, Madrigal Domínguez RE, Menchén L, Pérez Calle JL, Piqueras M, Dueñas Sadornil C, Botella B, Martínez-Pérez TJ, Ramos L, Rodríguez-Grau MC, San Miguel E, Fernández Forcelledo JL, Fradejas Salazar PM, García-Sepulcre M, Gutiérrez A, Llaó J, Sesé Abizanda E, Boscá-Watts M, Iyo E, Keco-Huerga A, Martínez Bonil C, Peña González E, Pérez-Galindo P, Varela P, Gisbert JP; To-ReWard Study Group. Chaparro M, et al. Among authors: vicente lidon r. Am J Gastroenterol. 2023 Jul 1;118(7):1237-1247. doi: 10.14309/ajg.0000000000002145. Epub 2022 Dec 14. Am J Gastroenterol. 2023. PMID: 36716287
Translation into Spanish and validation of a short questionnaire to measure the control of inflammatory bowel disease from the patient's perspective: IBD-Control, EII-Control.
Vicente Lidón R, García López S, Corsino Roche P, Boudet Barraca JM, Sanz Segura P, García Cámara P, Sierra Moros E, Gomollón García F. Vicente Lidón R, et al. Gastroenterol Hepatol. 2022 Aug-Sep;45(7):524-534. doi: 10.1016/j.gastrohep.2021.08.001. Epub 2021 Aug 21. Gastroenterol Hepatol. 2022. PMID: 34428475 English, Spanish.
19 results